Proteins and Peptides
10 December 2013
Baxter Submits Application for FDA Approval of OBI-1 for Patients with Acquired Hemophilia A10 December 2013
CSL Behring Study Shows Kcentra® Superior to Plasma for Warfarin Reversal in Patients Requiring an Urgent Surgical Procedure10 December 2013
Baxter Files for Pediatric Indication of RIXUBIS (Coagulation Factor IX (Recombinant)] Treatment for Hemophilia B in the United States10 December 2013
New Phase 3 Data Confirm Long-Lasting Characteristics Of ALPROLIX™ and ELOCTATE™ Across Multiple Hemophilia Populations7 December 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX® for the Treatment of Peyronie’s Disease5 December 2013
Zealand informs that new data presented at the World Diabetes Congress support flexibility in timing of administration for Lyxumia®3 December 2013
Biotest-EpiVax Collaborative Research Targets New, Non-Immunogenic Treatment for Hemophilia A3 December 2013
Synageva BioPharma™ Completes Target Enrollment in Phase 3 ARISE Trial with Sebelipase Alfa in Children and Adults with LAL Deficiency2 December 2013
Polaris Group Files New IND for ADI-PEG 20 in Leukemia27 November 2013
Durata Therapeutics Announces FDA’s Acceptance for Priority Review of NDA for Dalvance(TM) (dalbavancin hydrochloride)25 November 2013
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy21 November 2013
European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Fibrocaps Hemostatic Agent20 November 2013
FDA Advisory Committee Recommends Approval for BioMarin’s Vimizim(TM) for the Treatment of Patients With Morquio A Syndrome18 November 2013
Teva Announces Updates to Oncology Biologic PortfolioNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports